A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

A new method is developed to track dormant HIV-infected cells. This breakthrough may lead to new treatments that eliminate ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.

Protein crystallization at the SER-CAT beamline at Argonne’s Advanced Photon Source proved key to the discovery of a new HIV vaccine candidate.

Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

Sarah Macadam, chief executive of Thames Valley Positive Support, expects the A&E testing will lead to an increase in demand ...

Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...

Human Immunodeficiency Virus, or HIV, swept through the nation ... the first successful agent in reducing the spread of HIV, new cases started to reduce. But all these years later, HIV and other ...

The U.S. faces an ongoing HIV epidemic, with women, particularly women of color, bearing a heavy burden. While there have ...

according to a new study. By targeting infected cells in the brain, drug may clear virus ... Proof-of-Concept Study to Find Functional Cure for HIV July 24, 2024 — Researchers conducted a ...